MedPath

Evaluation of Carbohydrates

Not Applicable
Completed
Conditions
Glycemic Index
Interventions
Other: CHO Control 1 and 2 Glucose
Other: CHO Experimental 4 Maltodextrin
Other: CHO Experimental 2 Digestion Resistant
Other: CHO Experimental 1 Slowly Digested
Other: CHO Experimental 3 Low Sugar
Registration Number
NCT03242122
Lead Sponsor
Abbott Nutrition
Brief Summary

The study is open-label with a randomized, cross-over design using standard Gl methodology.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Subjects are males or non-pregnant females in good health.
  • Subjects must be eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.
Exclusion Criteria
  • Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes or a heart condition.
  • Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
CHO Control 2 GlucoseCHO Control 1 and 2 Glucose25 g glucose
CHO Experimental 4 MaltodextrinCHO Experimental 4 Maltodextrin25 g maltodextrin
CHO Experimental 2 Digestion ResistantCHO Experimental 2 Digestion Resistant25 g digestion-resistant carbohydrate blend
CHO Control 1 GlucoseCHO Control 1 and 2 Glucose25 g glucose
CHO Experimental 1 Slowly DigestedCHO Experimental 1 Slowly Digested25 g slowly-digested carbohydrate blend
CHO Experimental 3 Low SugarCHO Experimental 3 Low Sugar25 g low sugar carbohydrate blend
Primary Outcome Measures
NameTimeMethod
Blood glucose response curve0 to 120 minutes

area under the curve (AUG)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Glycemic Index Laboratories Inc

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath